Century Therapeutics Statistics
Total Valuation
IPSC has a market cap or net worth of $211.25 million. The enterprise value is $61.51 million.
| Market Cap | 211.25M |
| Enterprise Value | 61.51M |
Important Dates
The next estimated earnings date is Wednesday, August 7, 2024, before market open.
| Earnings Date | Aug 7, 2024 |
| Ex-Dividend Date | n/a |
Share Statistics
IPSC has 84.50 million shares outstanding. The number of shares has increased by 6.29% in one year.
| Shares Outstanding | 84.50M |
| Shares Change (YoY) | +6.29% |
| Shares Change (QoQ) | +3.84% |
| Owned by Insiders (%) | 28.22% |
| Owned by Institutions (%) | 53.67% |
| Float | 37.78M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 154.20 |
| Forward PS | 22.15 |
| PB Ratio | 1.19 |
| P/FCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | 44.90 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 12.44, with a Debt / Equity ratio of 0.25.
| Current Ratio | 12.44 |
| Quick Ratio | n/a |
| Debt / Equity | 0.25 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | -975.45 |
Financial Efficiency
Return on equity (ROE) is -64.40% and return on invested capital (ROIC) is -65.62%.
| Return on Equity (ROE) | -64.40% |
| Return on Assets (ROA) | -35.00% |
| Return on Capital (ROIC) | -65.62% |
| Revenue Per Employee | $8,303 |
| Profits Per Employee | -$808,915 |
| Employee Count | 165 |
| Asset Turnover | 0.00 |
| Inventory Turnover | n/a |
Taxes
In the past 12 months, IPSC has paid $674,000 in taxes.
| Income Tax | 674,000 |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -16.39% in the last 52 weeks. The beta is 1.40, so IPSC's price volatility has been higher than the market average.
| Beta (5Y) | 1.40 |
| 52-Week Price Change | -16.39% |
| 50-Day Moving Average | 2.89 |
| 200-Day Moving Average | 3.03 |
| Relative Strength Index (RSI) | 45.16 |
| Average Volume (20 Days) | 437,484 |
Short Selling Information
The latest short interest is 1.79 million, so 2.12% of the outstanding shares have been sold short.
| Short Interest | 1.79M |
| Short Previous Month | 1.56M |
| Short % of Shares Out | 2.12% |
| Short % of Float | 4.74% |
| Short Ratio (days to cover) | 5.07 |
Income Statement
In the last 12 months, IPSC had revenue of $1.37 million and -$133.47 million in losses. Loss per share was -$2.21.
| Revenue | 1.37M |
| Gross Profit | 1.37M |
| Operating Income | -145.77M |
| Pretax Income | -132.80M |
| Net Income | -133.47M |
| EBITDA | -118.22M |
| EBIT | -132.66M |
| Loss Per Share | -$2.21 |
Balance Sheet
The company has $194.00 million in cash and $44.25 million in debt, giving a net cash position of $149.74 million or $1.77 per share.
| Cash & Cash Equivalents | 194.00M |
| Total Debt | 44.25M |
| Net Cash | 149.74M |
| Net Cash Per Share | $1.77 |
| Equity (Book Value) | 177.88M |
| Book Value Per Share | 2.11 |
| Working Capital | 183.75M |
Cash Flow
In the last 12 months, operating cash flow was -$89.38 million and capital expenditures -$9.28 million, giving a free cash flow of -$98.66 million.
| Operating Cash Flow | -89.38M |
| Capital Expenditures | -9.28M |
| Free Cash Flow | -98.66M |
| FCF Per Share | -$1.58 |
Margins
Gross margin is 100.00%, with operating and profit margins of -10,640.44% and -9,742.41%.
| Gross Margin | 100.00% |
| Operating Margin | -10,640.44% |
| Pretax Margin | -9,693.21% |
| Profit Margin | -9,742.41% |
| EBITDA Margin | -8,628.83% |
| EBIT Margin | -9,683.28% |
| FCF Margin | -7,201.53% |
Dividends & Yields
IPSC does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -6.29% |
| Shareholder Yield | -6.29% |
| Earnings Yield | -63.18% |
| FCF Yield | -46.70% |
Analyst Forecast
The average price target for IPSC is $14.17, which is 466.80% higher than the current price. The consensus rating is "Strong Buy".
| Price Target | $14.17 |
| Price Target Difference | 466.80% |
| Analyst Consensus | Strong Buy |
| Analyst Count | 6 |
| Revenue Growth Forecast (5Y) | 121.04% |
| EPS Growth Forecast (5Y) | n/a |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
IPSC has an Altman Z-Score of -2.62 and a Piotroski F-Score of 2. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | -2.62 |
| Piotroski F-Score | 2 |